Switch to: References

Add citations

You must login to add citations.
  1. Negotiating the Relationship Between Addiction, Ethics, and Brain Science.Daniel Z. Buchman, Wayne Skinner & Judy Illes - 2010 - American Journal of Bioethics Neuroscience 1 (1):36-45.
    Advances in neuroscience are changing how mental health issues such as addiction are understood and addressed as a brain disease. Although a brain disease model legitimizes addiction as a medical condition, it promotes neuro-essentialist thinking and categorical ideas of responsibility and free choice, and undermines the complexity involved in its emergence. We propose a “biopsychosocial systems” model where psychosocial factors complement and interact with neurogenetics. A systems approach addresses the complexity of addiction and approaches free choice and moral responsibility within (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   11 citations  
  • Current Bibliography of the History of Science and Its Cultural Influences 2002.Stephen P. Weldon - 2002 - Isis 93:1-237.
    No categories
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
    		•
  • Current Bibliography of the History of Science and Its Cultural Influences 2004.Stephen P. Weldon - 2004 - Isis 95:1-249.
    No categories
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
    		•
  • How to Make Your Relationship Work? Aesthetic Relations with Technology.Jeannette Pols - 2017 - Foundations of Science 22 (2):421-424.
    Discussing the workings of technology in care as aesthetic rather than as ethical or epistemological interventions focusses on how technologies engage in and change relations between those involved. Such an aesthetic study opens up a repertoire to address values that are abundant in care, but are as yet hardly theorized. Kamphof studies the problem that sensor technology reveals things about the elderly patients without the patients being aware of this. I suggest improvement of these relations may be considered in aesthetic (...)
    Direct download (7 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  • Between truth and hope: on Parkinson’s disease, neurotransplantation and the production of the ‘self’.Tiago Moreira & Paolo Palladino - 2005 - History of the Human Sciences 18 (3):55-82.
    In this article, we argue that contemporary biomedicine is shaped by two, seemingly incommensurable, organizational logics, the ‘regime of truth’ and the ‘regime of hope’. We articulate their features by drawing on debates sparked by the recent clinical trial of a new approach to the treatment of Parkinson’s Disease. We also argue that the ‘self’ is configured in the very same process whereby these two organizational logics interlock and become mutually dependent, so that the ‘self’ might be said to be (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   7 citations  
  • Questions of evidence in evidence-based policy.Eleonora Montuschi - 2009 - Axiomathes 19 (4):425-439.
    Evidence-based approaches to policy-making are growing in popularity. A generally embraced view is that with the appropriate evidence at hand, decision and policy making will be optimal, legitimate and publicly accountable. In practice, however, evidence-based policy making is constrained by a variety of problems of evidence. Some of these problems will be explored in this article, in the context of the debates on evidence from which they originate. It is argued that the source of much disagreement might be a failure (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   7 citations  
  • Profitable failure: antidepressant drugs and the triumph of flawed experiments.Linsey McGoey - 2010 - History of the Human Sciences 23 (1):58-78.
    Drawing on an analysis of Irving Kirsch and colleagues’ controversial 2008 article in PLoS [Public Library of Science] Medicine on the efficacy of SSRI antidepressant drugs such as Prozac, I examine flaws within the methodologies of randomized controlled trials (RCTs) that have made it difficult for regulators, clinicians and patients to determine the therapeutic value of this class of drug. I then argue, drawing analogies to work by Pierre Bourdieu and Michael Power, that it is the very limitations of RCTs (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   3 citations